According to a recent study, treatment with the multikinase inhibitor entrectinib produces durable responses in all of the following soft-tissue sarcomas EXCEPT...
Adjuvant EGFR TKI treatment for patients with EGFR-mutant NSCLC after complete resection offers a significant disease-free survival advantage, according to a recent meta-analysis.
High levels of a specific enzyme are linked with lower survival rates in patients with multiple myeloma, according to a new study.
Researchers have developed an algorithm for differentiating between healthy women and those with ovarian cancer, as well as differentiating BRCA1 mutated-disease from wild-type disease.
Vaccine-based immunotherapy after surgery or radiotherapy did not increase survival in patients with localized non-small-cell lung cancer, according to a recent meta-analysis.
A myriad of factors including lack of guidelines, wealth of drug options, cost concerns, and varying efficacy make treatment decisions for rheumatoid arthritis a challenge.
A clinical pathway for coordinating the care of patients with heart failure may reduce admissions to the ED without increasing ED congestion.
Upregulation of a specific protein may be an indicator of radiation resistance in patients with resected non-small cell lung cancer who received radiotherapy.
A recent study examined whether a history of Epstein-Barr virus positivity or immunosuppression affects outcomes in patients with a type of B-cell lymphoma.
The US FDA has granted approval to an adjuvant therapy for HER2-positive breast cancer at high risk of recurrence.